Multicenter prospective validation of PanClaudinAI: An AI for predicting Claudin 18.2 from CT in pancreatic cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers ...
Outcomes with sacituzumab govitecan (SG) in patients (pts) with advanced urothelial carcinoma (aUC) and variant histologies (VH): Analysis of the UNITE study. This is an ASCO Meeting Abstract from the ...
Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.